Fueled by aggressive marketing that hyped atypical antipsychotics as safe and effective for off-label uses, states an article in The Washington Post yesterday, sales of the drugs for off-label uses doubled from 1995 to 2008, with people seeking out antipsychotics for uses such as insomnia. Sales of antipsychotics as a class rose more than 169% between 2001 and 2010, making them one of the best-selling drugs; ahead of antidepressants and sometimes cholesterol medications.
Article → Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.